MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202647089173 A) filed by Protagonist Therapeutics, Inc. on July 22, 2026, for Human Interleukin (il)-17 Cytokine Binding Peptides.
Inventors include Bhandari, Ashok; Zhang, Jie; Bourne, Greg, Thomas; Daniel, James; Duncan, Jack; Tang, Fei; Yang, Bo; Tran, Tran, Trung; and Halladay, Jason.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: The present disclosure provides peptide compounds that inhibit human IL-17 cytokines. The present disclosure also provide pharmaceutical compositions that include the peptide compounds. In addition, the present disclosure also provides methods of use of the peptide compounds, such as methods of treating or preventing diseases, conditions or disorders mediated or associated with IL-17.
Disclaimer: Curated by HT Syndication.
